GigaGen Inc

One Tower Place, South San Francisco, CA, 94080, US

2010

11-50

View Employees in GigaGen Inc
Real-Time AI Research
0 search queries left
FlashIntel GPT
Hello! I'm FlashIntel GPT, your personal AI search assistant. Feel free to ask me anything about GigaGen Inc, and I'll do my best to assist you.
You

Tell me more about GigaGen Inc?

FlashIntel GPT
GigaGen Inc, a subsidiary of Grifols, focuses on advancing transformative antibody drugs for immune deficiency, infectious diseases, and checkpoint resistant cancers. Their single-cell antibody discovery and development platforms capture and recreate complete immune repertoires, enabling the creation of first-in-class recombinant polyclonal antibody therapies for the treatment of infectious diseases

Display the latest LinkedIn Posts related to their company.

Are there any recent company initiatives this company is involved in?

What pain points do professionals in their industry face?

Research Details
News &Insights
Key People

view 38 associated members

GigaGen Inc In Short

See Hup Seng is a construction company based in Singapore with 23 employees. Specializing in the construction industry, the company offers a range of services including business investment relations, web design, and web design. With a focus on cutting-edge construction, See Hup Seng is committed to delivering high-quality and innovative solutions to its clients.

Company Description of GigaGen Inc

GigaGen, a subsidiary of Grifols, is advancing transformative antibody drugs for immune deficiency, infectious diseases and checkpoint resistant cancers by leveraging industry-leading, single-cell technologies. GigaGen’s novel technology platforms uniquely capture and recreate complete immune repertoires as functional antibody libraries. This approach has enabled the creation of first-in-class recombinant polyclonal antibody therapies for the treatment of infectious diseases. GigaGen’s lead oncology asset, GIGA-564, is an anti-CTLA-4 monoclonal antibody that has demonstrated improved anti-tumor efficacy in vivo through a unique mechanism of action. GigaGen is leveraging its proprietary technology platforms for the continued discovery of novel recombinant polyclonal drugs and monoclonal antibodies to treat life-threatening diseases.

One Tower Place, South San Francisco, CA, 94080, US

+1 4*******

38

Show More

What does GigaGen Inc offer?

GigaGen Inc, a subsidiary of Grifols, focuses on advancing transformative antibody drugs for immune deficiency, infectious diseases, and checkpoint resistant cancers. Their single-cell antibody discovery and development platforms capture and recreate complete immune repertoires, enabling the creation of first-in-class recombinant polyclonal antibody therapies for the treatment of infectious diseases